RHOC and head and neck squamous cell carcinoma: Two studies have demonstrated that miR-138 inhibits the migration and invasion of tongue squamous cell carcinoma (TSCC) and head and neck squamous cell carcinoma (HNSCC) cells, respectively, by targeting RhoC mRNA [74, 75].